KRYS - Krystal Biotech - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KRYS is currently covered by 8 analysts with an average price target of $259.41. This is a potential upside of $42.44 (19.56%) from yesterday's end of day stock price of $216.97.

Krystal Biotech's activity chart (see below) currently has 115 price targets and 98 ratings on display. The stock rating distribution of KRYS is 88.89% BUY and 11.11% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 85.97% with an average time for these price targets to be met of 286.42 days.

Highest price target for KRYS is $255, Lowest price target is $189, average price target is $213.5.

Most recent stock forecast was given by GEULAH LIVSHITS from CHARDAN CAPITAL on 03-Nov-2025. First documented stock forecast 17-Oct-2017.

Currently out of the existing stock ratings of KRYS, 24 are a BUY (88.89%), 3 are a HOLD (11.11%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$220

$7.98 (3.76%)

$216

22 days ago
(03-Nov-2025)

9/15 (60%)

$22.15 (11.20%)

394

Hold

$198

$-14.02 (-6.61%)

$166

22 days ago
(03-Nov-2025)

5/6 (83.33%)

$0.15 (0.08%)

206

Buy

$255

$42.98 (20.27%)

$192

1 months 9 days ago
(16-Oct-2025)

3/4 (75%)

$64.77 (34.05%)

284

Buy

$240

$27.98 (13.20%)

$240

2 months 11 days ago
(14-Sep-2025)

24/36 (66.67%)

$84.29 (54.13%)

210

Buy

$202

$-10.02 (-4.73%)

$130

6 months 19 days ago
(06-May-2025)

5/5 (100%)

$65.2 (47.66%)

319

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KRYS (Krystal Biotech) average time for price targets to be met?

On average it took 286.42 days on average for the stock forecasts to be realized with a an average price target met ratio 85.97

Which analyst has the current highest performing score on KRYS (Krystal Biotech) with a proven track record?

JOSH SCHIMMER

Which analyst has the most public recommendations on KRYS (Krystal Biotech)?

Josh Schimmer works at CANTOR FITZGERALD and has 3 price targets and 2 ratings on KRYS

Which analyst is the currently most bullish on KRYS (Krystal Biotech)?

Alec Stranahan with highest potential upside - $42.98

Which analyst is the currently most reserved on KRYS (Krystal Biotech)?

Wangzhi Li with lowest potential downside - -$162.02

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?